SoFi reported stellar membership and revenue growth in the third quarter. The business is projecting a huge profit gain in 2025 compared to the year before. Thanks to strong financial performance, the ...

CRISPR Therapeutics reached a significant milestone a couple of years ago: its first product approval. The company’s stock, once a highflier, has declined from its peak. First, let's talk a bit about ...